Read + Share
Amedeo Smart
Independent Medical Education
Yu Y, Pan Y, Zhou J, Mu S, et al. Dacomitinib in the treatment of EGFR-mutated non-small cell lung cancer with brain metastases: an open-label, multicenter, phase II study. Lung Cancer 2025;207:108710.PMID: 40811939
Email
LinkedIn
Privacy Policy